Endothelin-1 exerts a preconditioning-like cardioprotective effect against ischaemia/reperfusion injury via the ETA receptor and the mitochondrial KATP channel in the rat in vivo

British Journal of Pharmacology

Volumn 144, Issue 3, 2005, Pages 331-337

  Gourine, Audrey V ^a   Molosh, Audrey I ^b,c   Poputnikov, Dmitry ^a   Bulhak, Aliaksandr ^a   Sjöquist, Per Ove ^a   Pernow, John ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b REPUBLICAN SCIENTIFIC AND PRACTICAL CENTRE CARDIOLOGY   (Belarus)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 hydroxydecanoic acid; Endothelin 1; Glibenclamide; Infarct size; Ischaemia; Preconditioning; Rat; Reperfusion

Indexed keywords

5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATE; DARUSENTAN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; GLIBENCLAMIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 14644412903     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706050     Document Type: Article

References (39)

1. ARAI, H., HORI, S., ARAMORI, I., OHKUBO, H. & NAKANISHI, S. (1990). Cloning and expression of a cDNA encoding an endothelin receptor. Nature, 348, 730-732.
2. Auchampach, J.A., Grover, G.J. & Gross, G.J. (1992). Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc. Res., 26, 1054-1062.
3. BANERJEE, A., LOCKE-WINTER, C., ROGERS, K.B., MITCHELL, M.B., BREW, E.C., CAIRNS, C.B., BENSARD, D.D. & HARKEN, A.H. (1993). Preconditioning against myocardial dysfunction after ischaemia and reperfusion by an alpha 1-adrenergic mechanism. Circ. Res., 73, 656-670.
4. BUGGE, E. & YTREHUS, K. (1996a). Bradykinin protects against infarction but does not mediate ischemic preconditioning in the isolated rat heart. J. Mol. Cell. Cardiol., 28, 2333-2341.
5. ATP channels in the isolated rat heart. Cardiovasc. Res., 32, 920-929.
6. CAVE, A.C., COLLIS, C.S., DOWNEY, J.M. & HEARSE, D.J. (1993). Improved functional recovery by ischaemic preconditioning is not mediated by adenosine in the globally ischaemic isolated rat heart. Cardiovasc. Res., 27, 663-668.
7. COHEN, M.V., YANG, X.M., LIU, G.S., HEUSCH, G. & DOWNEY, J.M. (2001). Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K(ATP) channels. Circ. Res., 89, 273-278.
8. DE NUCCI, G., GRYGLEWSKI, R.J., WARNER, T.D. & VANE, J.R. (1988). Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled. Proc. Natl. Acad. Sci. U.S.A., 85, 2334-2338.
9. A receptor, platelet-activating factor and thromboxane A2. Br. J. Pharmacol., 112, 963-971.
10. FRYER, R.M., EELLS, J.T., HSU, A.K., HENRY, M.M. & GROSS, G.J. (2000a). Ischemic preconditioning in rats: role of mitochondrial K(ATP) channel in preservation of mitochondrial function. Am. J. Physiol. Heart Circ. Physiol., 278, H305-H312.
11. FRYER, R.M., HSU, A.K. & GROSS, G.J. (2001). Mitochondrial K(ATP) channel opening is important during index ischemia and following myocardial reperfusion in ischemic preconditioned rat hearts. J. Mol. Cell. Cardiol., 33, 831-834.
12. FRYER, R.M., HSU, A.K., NAGASE, H. & GROSS, G.J. (2000b). Opioid-induced cardioprotection against myocardial infarction and arrhythmias: mitochondrial versus sarcolemmal ATP-sensitive potassium channels. J. Pharmacol. Exp. Ther., 294, 451-457.
13. GALIUTO, L., DEMARIA, A.N., DEL BALZO, U., MAY-NEWMAN, K., FLAIM, S.F., WOLF, P.L., KIRCHENGAST, M. & ILICETO, S. (2000). Ischemia-reperfusion injury at the microvascular level: treatment by endothelin A-selective antagonist and evaluation by myocardial contrast echocardiography. Circulation, 102, 3111-3116.
14. A-receptor antagonist, BQ123, on ischemic arrhythmias in anesthetized rats. J. Cardiovasc. Pharmacol., 25, 634-642.
15. GONON, A.T., WANG, Q-D. & PERNOW, J. (1998a). The endothelin A receptor antagonist LU 135252 protects the myocardium from neutrophil injury during ischemia/reperfusion. Cardiovasc. Res., 39, 674-682.
16. GONON, A.T., WANG, Q-D., SHIMIZU, M. & PERNOW, J. (1998b). The novel non-peptide selective endothelin A receptor antagonist LU 135252 protects against myocardial ischaemic and reperfusion injury in the pig. Acta Physiol. Scand., 163, 131-137.
17. GROSS, G.J. & AUCHAMPACH, J.A. (1992). Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ. Res., 70, 223-233.
18. GROSS, G.J. & FRYER, R.M. (2000). Mitochondrial K(ATP) channels: triggers or distal effectors of ischemic or pharmacological preconditioning? Circ. Res., 87, 431-433.
19. GROVER, G.J., DZWONCZYK, S. & PARHAM, C.S. (1993). The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion. Cardiovasc. Res., 27, 1613-1618.
20. LI, L., FINK, G.D., WATTS, S.W., NORTHCOTT, C.A., GALLIGAN, J.J., PAGANO, P.J. & CHEN, A.F. (2003). Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension. Circulation, 107, 1053-1058.
21. MCCLELLAN, G., WEISBERG, A., ROSE, D. & WINEGRAD, S. (1994). Endothelial cell storage and release of endothelin as a cardioregulatory mechanism. Circ. Res., 75, 85-96.
22. MUNTER, K., EHMKE, H. & KIRCHENGAST, M. (1999). Maintenance of blood pressure in normotensive dogs by endothelin. Am. J. Physiol., 276, H1022-H1027.
23. O'ROURKE, B. (2004). Evidence for mitochondrial K+ channels and their role in cardioprotection. Circ. Res., 94, 420-432.
24. PAIN, T., YANG, X.M., CRITZ, S.D., YUE, Y., NAKANO, A., LIU, G.S., HEUSCH, G., COHEN, M.V. & DOWNEY, J.M. (2000). Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ. Res., 87, 460-466.
25. PEART, J.N. & GROSS, G.J. (2002). Sarcolemmal and mitochondrial K(ATP) channels and myocardial ischemic preconditioning. J. Cell Mol. Med., 6, 453-464.
26. PERNOW, J., HEMSÉN, A. & LUNDBERG, J.M. (1989). Tissue specific distribution, clearance and vascular effects of endothelin in the pig. Biochem. Biophys. Res. Comm., 161, 647-653.
27. PERNOW, J. & WANG, Q-D. (1997). Endothelin in myocardial ischaemia and reperfusion. Cardiovasc. Res., 33, 518-526.
28. ATP channels in rat heart: blockade of ischemic and acetylcholine-mediated preconditioning by glibenclamide. Am. J. Physiol., 271 (Part 2), H23-H28.
29. RUBANYI, G.M. & POLOKOFF, M.A. (1994). Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol. Rev., 46, 325-415.
30. SCHULTZ, J.E., YAO, Z., CAVERO, I. & GROSS, G.J. (1997). Glibenclamide-induced blockade of ischemic preconditioning is time dependent in intact rat heart. Am. J. Physiol., 272 (Part 2). H2607-H2615.
31. SCHULZ, R., GRES, P. & HEUSCH, G. (2003). Activation of ATP-dependent potassium channels is a trigger but not a mediator of ischaemic preconditioning in pigs. Br. J. Pharmacol., 139, 65-72.
32. TAKEUCHI, Y., KIHARA, Y., INAGAKI, K., YONEDA, T. & SASAYAMA, S. (2001). Endothelin-1 has a unique oxygen-saving effect by increasing contractile efficiency in the isolated rat heart. Circulation, 103, 1557-1563.
33. TEERLINK, J.R., BREU, V., SPRECHER, U., CLOZEL, M. & CLOZEL, J.P. (1994). Potent vasoconstriction mediated by endothelin ETB receptors in canine coronary arteries. Circ. Res., 74, 105-114.
34. WANG, P., GALLAGHER, K.P., DOWNEY, J.M. & COHEN, M.V. (1996). Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit heart. J. Mol. Cell Cardiol., 28, 579-588.
35. WANG, Q.D., LI, X.S., LUNDBERG, J.M. & PERNOW, J. (1995). Protective effects of non-peptide endothelin receptor antagonist bosentan on myocardial ischaemic and reperfusion injury in the pig. Cardiovasc. Res., 29, 805-812.
36. YANAGISAWA, M., KURIHARE, H., KIMURA, S., TOMOBE, Y., KOBAYASHI, M., MITSUI, Y., YAZAKI, Y., GOTO, K. & MASAKI, T. (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 332, 411-415.
37. YELLON, D.M., BAXTER, G.F., GARCIA-DORADO, D., HEUSCH, G. & SUMERAY, M.S. (1998). Ischaemic preconditioning: present position and future directions. Cardiovasc. Res., 37, 21-33.
38. YORIKANE, R. & KOIKE, H. (1990). The arrhythmogenic action of endothelin in rats. Jpn. J. Pharmacol., 53, 259-263.
39. ZHANG, D.X., CHEN, Y.F., CAMPBELL, W.B., ZOU, A.P., GROSS, G.J. & LI, P.L. (2001). Characteristics and superoxide-induced activation of reconstituted myocardial mitochondrial ATP-sensitive potassium channels. Circ. Res., 89, 1177-1183.